Drug Cytotoxicity Efficacy
Drug Cytotoxicity Efficacy - Related Videos
08:04
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
0 Views •
Cited by 8 •
2014
The protocol reported here allows the evaluation of the efficacy of photodynamic therapy (PDT) in cell lines and the optimization of the PDT settings before applying the therapy in animal models.
09:57
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
0 Views •
Cited by 15 •
2017
We have developed a modular high-throughput screening system for discovering novel compounds against Mycobacterium tuberculosis, targeting intracellular and in-broth growing bacteria as well as cytotoxicity against the mammalian host cell.
03:40
β-Galactosidase Assay to Evaluate Drug-Induced Cytotoxicity in Parasites
0 Views •
2023
In this video, we describe a simple and robust method to determine the cytotoxic potential of a trypanocidal drug against a parasite, Trypanosoma cruzi, expressing the β-galactosidase enzyme. β-galactosidase serves as a cell lysis indicator, and its activity can be used to assess the effects of the drug.
02:48
Determining Antiviral Efficacy of Experimental Drugs Through a Plaque Assay
0 Views •
2025
This video demonstrates the method to perform a plaque assay using a virus obtained from infected porcine cornea. The porcine cornea is used to test the antiviral efficacy of experimental drugs.
05:14
An Assay to Evaluate Drug Efficacy against a Mycobacterium tuberculosis Infection Model
0 Views •
2025
This video demonstrates an assay to evaluate the efficacy of drugs against Mycobacterium tuberculosis (Mtb) infection. An in vitro infection model containing Mtb/macrophage aggregates is generated that mimics in vivo infection. Upon introducing suitable antibiotics, their efficacy is tested via resuzarin assay to monitor the survival of bacteria with increasing drug concentrations.
FAQs
Dose-response curves show how measured cellular effects change as drug concentration increases. Researchers can use the curve to compare compounds and estimate potency, including the concentration associated with a defined level of effect. This approach provides more information than testing a single concentration because it reveals the relationship between exposure level and the strength of the biological response.
Cell viability, proliferation, and membrane integrity provide different ways to characterize drug effects in cultured cells. Viability reflects whether cells remain functional or alive, proliferation indicates changes in cell growth, and membrane integrity reveals damage to the cell boundary. Selecting among these readouts helps align the measurement with the intended biological effect being investigated.
A drug may show activity against diseased cells while also affecting healthy cells, so testing both populations adds essential context. The comparison helps researchers determine whether observed cytotoxicity is preferentially associated with the intended target cell type or reflects broader cellular harm. These findings support evaluation of treatment suitability and contribute to safety assessment during development.
Testing a range of concentrations helps identify where a compound begins to produce its intended cellular effect and how strongly that effect changes with additional exposure. Researchers can compare effective concentrations with effects observed in healthy cells to evaluate whether a potentially useful treatment range exists. This analysis supports rational treatment design rather than relying on an isolated dose.
The workflow begins by exposing cultured cells to multiple concentrations of a therapeutic compound. Researchers then measure a selected outcome, such as viability, proliferation, or membrane integrity, across those conditions. Plotting the measurements against concentration produces a dose-response relationship that can be used to compare candidate drugs and estimate the concentration required for a defined effect.
Drug cytotoxicity measurements help compare candidate compounds before further development and provide evidence for both efficacy and potential harm. In medicine, the results can indicate whether a compound affects diseased cells more than healthy cells, guide identification of effective treatment ranges, and inform safety assessment. They also contribute to rational treatment design and broader preclinical evaluation.